Waters Parkerson & Co’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.3M Sell
351,577
-146
-0% -$16.9K 2.17% 14
2025
Q4
$37M Buy
351,723
+10,810
+3% +$1.01M 1.82% 17
2025
Q3
$28.6M Buy
340,913
+7,831
+2% +$645K 1.39% 26
2025
Q2
$26.4M Buy
333,082
+12,665
+4% +$1.01M 1.32% 27
2025
Q1
$28.8M Buy
320,417
+12,395
+4% +$1.16M 1.53% 21
2024
Q4
$30.6M Buy
308,022
+5,743
+2% +$592K 1.61% 19
2024
Q3
$34.3M Sell
302,279
-4,453
-1% -$529K 1.74% 21
2024
Q2
$38M Sell
306,732
-1,543
-0.5% -$199K 2.02% 16
2024
Q1
$40.7M Sell
308,275
-12,883
-4% -$1.59M 2.09% 15
2023
Q4
$35M Sell
321,158
-9,922
-3% -$1.03M 1.94% 17
2023
Q3
$34.1M Sell
331,080
-1,823
-0.5% -$196K 2.04% 15
2023
Q2
$38.4M Sell
332,903
-5,122
-2% -$582K 2.17% 15
2023
Q1
$36M Sell
338,025
-542
-0.2% -$58.5K 2.12% 14
2022
Q4
$37.6M Sell
338,567
-6,894
-2% -$705K 2.26% 15
2022
Q3
$29.8M Sell
345,461
-1,582
-0.5% -$141K 1.99% 16
2022
Q2
$31.6M Buy
347,043
+4,034
+1% +$358K 2% 17
2022
Q1
$28.1M Buy
343,009
+4,035
+1% +$318K 1.57% 23
2021
Q4
$26M Sell
338,974
-10,687
-3% -$851K 1.37% 27
2021
Q3
$26.3M Buy
349,661
+4,993
+1% +$380K 1.51% 22
2021
Q2
$26.8M Sell
344,668
-7,848
-2% -$584K 1.55% 21
2021
Q1
$25.9M Buy
352,516
+16,841
+5% +$1.24M 1.6% 21
2020
Q4
$26.2M Buy
335,675
+4,498
+1% +$344K 1.75% 19
2020
Q3
$26.2M Sell
331,177
-1,761
-0.5% -$138K 1.97% 14
2020
Q2
$24.6M Buy
332,938
+480
+0.1% +$36.1K 1.99% 16
2020
Q1
$24.4M Buy
332,458
+11,430
+4% +$898K 2.37% 13
2019
Q4
$27.9M Sell
321,028
-1,346
-0.4% -$111K 2.09% 16
2019
Q3
$25.9M Sell
322,374
-5,711
-2% -$458K 2.09% 17
2019
Q2
$26.3M Sell
328,085
-6,634
-2% -$508K 2.13% 17
2019
Q1
$26.6M Buy
334,719
+2,050
+0.6% +$153K 2.23% 17
2018
Q4
$24.3M Sell
332,669
-1,750
-0.5% -$124K 2.34% 16
2018
Q3
$22.6M Buy
334,419
+988
+0.3% +$62.9K 1.85% 21
2018
Q2
$19.3M Buy
333,431
+3,085
+0.9% +$174K 1.66% 25
2018
Q1
$17.2M Buy
330,346
+17,916
+6% +$968K 1.51% 27
2017
Q4
$16.8M Buy
312,430
+21,666
+7% +$1.2M 1.41% 30
2017
Q3
$17.8M Buy
290,764
+621
+0.2% +$37.6K 1.57% 28
2017
Q2
$17.7M Buy
290,143
+1,962
+0.7% +$119K 1.64% 27
2017
Q1
$17.5M Sell
288,181
-1,535
-0.5% -$93.1K 1.65% 27
2016
Q4
$16.3M Sell
289,716
-10,180
-3% -$596K 1.64% 28
2016
Q3
$17.9M Sell
299,896
-3,740
-1% -$219K 1.83% 24
2016
Q2
$16.7M Buy
303,636
+4,630
+2% +$246K 1.79% 27
2016
Q1
$15.1M Buy
299,006
+11,139
+4% +$546K 1.67% 27
2015
Q4
$14.5M Buy
287,867
+9,232
+3% +$465K 1.66% 28
2015
Q3
$13.1M Buy
278,635
+7,768
+3% +$413K 1.67% 28
2015
Q2
$14.7M Buy
270,867
+4,638
+2% +$260K 1.73% 28
2015
Q1
$14.6M Buy
266,229
+4,735
+2% +$268K 1.71% 28
2014
Q4
$14.2M Buy
261,494
+5,720
+2% +$319K 1.68% 27
2014
Q3
$14.5M Buy
255,774
+1,176
+0.5% +$66K 1.73% 28
2014
Q2
$14.1M Sell
254,598
-510
-0.2% -$27.8K 1.68% 28
2014
Q1
$13.8M Sell
255,108
-4,702
-2% -$243K 1.71% 28
2013
Q4
$12.4M Buy
259,810
+6,389
+3% +$292K 1.52% 30
2013
Q3
$11.5M Sell
253,421
-1,252
-0.5% -$57.2K 1.55% 29
2013
Q2
$11.3M Buy
+254,673
New +$11.4M 1.64% 27

Other funds holding MRK

Waters Parkerson & Co's MRK Position: Q1 2026 in Review

Waters Parkerson & Co reduced its Merck (MRK) stake by 0.04% in Q1 2026, selling an estimated $16.9K and leaving 351,577 shares worth $42.3M. The position accounts for 2.17% of the portfolio, ranked #14.

Waters Parkerson & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Waters Parkerson & Co held 351,577 shares of Merck worth $42.3M as of Q1 2026.
  • Waters Parkerson & Co sold 146 Merck shares in Q1 2026, an estimated $16.9K.
  • Merck made up 2.17% of Waters Parkerson & Co's portfolio in Q1 2026, its #14 holding.
  • Waters Parkerson & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Waters Parkerson & Co's 13F filing for Q1 2026, filed 29 Apr 2026.